MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Rowan JP | "Estrophasic" dosing: A new concept in oral contraceptive therapy. | 1999 | Am. J. Obstet. Gynecol. | pmid:9988834 |
Mills TM et al. | Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration. | 1976 | Am. J. Obstet. Gynecol. | pmid:998688 |
Al-Azzawi F et al. | Continuous combined hormone replacement therapy compared with tibolone. | 1999 | Obstet Gynecol | pmid:9932566 |
Ohman L et al. | Topical administration of progestational steroids in the eye and nose--a rapid absorption to the blood. | 1978 | Contraception | pmid:99284 |
Weiner E and Johansson ED | The influence of norethisterone oenanthate on ovarian function. | 1976 | Acta Endocrinol. | pmid:989667 |
Rowlands SC and Dakin L | Twelve years of injectable contraceptive use in a general practice. | 1998 | Br J Fam Plann | pmid:9882767 |
Briatico G et al. | Effects of contraceptive agents on drug metabolism in various animal species. | 1976 | Br. J. Pharmacol. | pmid:987822 |
Raudaskoski T et al. | Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy. | 1998 | Menopause | pmid:9872487 |
Trapnell CB et al. | Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. | 1998 | Clin. Pharmacol. Ther. | pmid:9871424 |
Ladinsky H et al. | Lack of influence of the phase of estrus cycle or treatment with steroid contraceptive drugs on cholinergic parameters in mouse and rat brain. | 1976 | Pharmacology | pmid:986656 |